Verified factor-similar pair

CSD vs QVMM

These two ETFs meet the same FF6 US comparison criteria: US-listed equity ETFs, the same USD model basis, at least one material non-market factor, and 100% overlap in statistically significant material factor exposure.

SMB
Similarity score
86
Verified similar

The score combines exposure-level distance, factor-vector shape, market-beta closeness, and a small backtested relative-Sharpe term.

Quick Read

  • QVMM has the higher backtested relative Sharpe (1.065 vs 0.927).
  • QVMM has the lower published fee (0.15% vs 0.67%).
  • QVMM is cheaper on dividend valuation (120 vs 420, where 100 is each fund's historical median).
  • QVMM has the stronger regression fit (adjusted R-squared 0.940 vs 0.833).

These are screening signals, not a complete review of portfolio construction, turnover, taxes, or trading quality.

CSD

Invesco S&P Spin-Off ETF
SMB
Adj. R2
0.833
Rel. Sharpe
0.927
Mkt beta
1.13
AUM
US$114M
MER
0.67%
Valuation
420

QVMM

Invesco S&P MidCap 400 QVM Multi-factor ETF
SMB
Adj. R2
0.940
Rel. Sharpe
1.065
Mkt beta
1.01
AUM
US$392M
MER
0.15%
Valuation
120

Factor Exposure Match

Blue bars compare raw factor beta magnitude. Green bars compare absolute t-stat strength. Dim bars indicate the t-stat is below 1.96.

SMB
CSD
+0.50
|t|
+6.6
QVMM
+0.59
|t|
+8.6
diff -0.09
HML
CSD
+0.15
|t|
+2.0
QVMM
+0.16
|t|
+2.2
diff -0.01
RMW
CSD
+0.06
|t|
+0.7
QVMM
+0.20
|t|
+3.1
diff -0.14
CMA
CSD
+0.03
|t|
+0.2
QVMM
+0.10
|t|
+1.1
diff -0.07
UMD
CSD
-0.02
|t|
-0.4
QVMM
+0.03
|t|
+0.6
diff -0.05

Why This Pair Matches

Exposure level
85
Exposure shape
99
Mkt beta diff
0.12
Rel. Sharpe diff
0.138

This comparison focuses on measured factor exposure. It does not compare holdings methodology, turnover, tax handling, or issuer process. Backtested relative Sharpe is a secondary signal rather than a stand-alone forecast. See methodology.

CSD fund page QVMM fund page US ETF Leaders US Universe
Important context

VerifiedBeta publishes educational ETF research, not personalized investment advice, portfolio management, or security recommendations. Funds that screen well here can still be unsuitable for your objectives, taxes, liquidity needs, or constraints. Review fund documents, methodology assumptions, and your own circumstances before acting. See the full disclaimer.